Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Multicenter, Double-blind, Randomized Placebo-controlled Phase IV Clinical Trial of Different Dosing Regimens of Tenoten® in the Treatment of Anxiety in Patients With Somatoform, Stress-related and Other Neurotic Disorders

NCT03036293 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT03036293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03036293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Multicenter, Double-blind, Randomized Placebo-controlled Phase IV Clinical Trial of Different Dosing Regimens of Tenoten® in the Treatment of Anxiety in Patients With Somatoform, Stress-related and Other Neurotic Disorders
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
February 8, 2017
Completion date
September 22, 2018
Enrollment
390 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety